Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Infarction | 45 | 2023 | 11403 | 2.370 |
Why?
|
Heart-Assist Devices | 11 | 2021 | 1235 | 1.900 |
Why?
|
Shock, Cardiogenic | 8 | 2021 | 599 | 1.830 |
Why?
|
Hirudins | 7 | 2017 | 177 | 1.770 |
Why?
|
Angioplasty, Balloon, Coronary | 17 | 2013 | 1867 | 1.700 |
Why?
|
Thrombolytic Therapy | 15 | 2023 | 2158 | 1.680 |
Why?
|
Pulmonary Embolism | 10 | 2023 | 2361 | 1.650 |
Why?
|
Embolectomy | 4 | 2023 | 130 | 1.510 |
Why?
|
Acute Coronary Syndrome | 11 | 2023 | 2263 | 1.350 |
Why?
|
Antithrombins | 4 | 2017 | 302 | 1.300 |
Why?
|
Catheterization, Peripheral | 3 | 2020 | 352 | 1.260 |
Why?
|
Out-of-Hospital Cardiac Arrest | 4 | 2020 | 317 | 1.250 |
Why?
|
Fibrinolytic Agents | 12 | 2021 | 2124 | 1.220 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2020 | 1253 | 1.210 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 9 | 2019 | 647 | 1.170 |
Why?
|
Electrocardiography | 21 | 2020 | 6386 | 1.140 |
Why?
|
Intra-Aortic Balloon Pumping | 5 | 2021 | 220 | 1.080 |
Why?
|
Myocardial Revascularization | 6 | 2021 | 847 | 1.060 |
Why?
|
Stents | 14 | 2020 | 3212 | 0.970 |
Why?
|
Coronary Angiography | 21 | 2023 | 4411 | 0.940 |
Why?
|
Heparin | 10 | 2019 | 1620 | 0.920 |
Why?
|
Hospital Mortality | 18 | 2020 | 5141 | 0.900 |
Why?
|
Coronary Artery Disease | 13 | 2022 | 6290 | 0.860 |
Why?
|
Thrombectomy | 6 | 2023 | 681 | 0.840 |
Why?
|
Aortic Valve Stenosis | 8 | 2021 | 1844 | 0.830 |
Why?
|
Peptide Fragments | 7 | 2020 | 5111 | 0.800 |
Why?
|
Anticoagulants | 8 | 2018 | 4375 | 0.740 |
Why?
|
Myocardial Reperfusion | 7 | 2013 | 350 | 0.730 |
Why?
|
Treatment Outcome | 72 | 2023 | 62040 | 0.720 |
Why?
|
Platelet Aggregation Inhibitors | 14 | 2020 | 3015 | 0.690 |
Why?
|
Laboratories, Hospital | 1 | 2020 | 197 | 0.690 |
Why?
|
Vena Cava Filters | 2 | 2020 | 258 | 0.670 |
Why?
|
Pericarditis | 2 | 2020 | 115 | 0.650 |
Why?
|
Coronary Restenosis | 4 | 2008 | 425 | 0.630 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2022 | 248 | 0.620 |
Why?
|
Patient Care Team | 2 | 2020 | 2581 | 0.610 |
Why?
|
Hemorrhage | 7 | 2020 | 3279 | 0.610 |
Why?
|
Hospital Costs | 6 | 2018 | 977 | 0.610 |
Why?
|
Coronary Thrombosis | 4 | 2023 | 489 | 0.600 |
Why?
|
Coronary Vessels | 8 | 2023 | 2978 | 0.580 |
Why?
|
Peripheral Vascular Diseases | 1 | 2019 | 551 | 0.570 |
Why?
|
Cardiology | 8 | 2022 | 1645 | 0.560 |
Why?
|
Subclavian Steal Syndrome | 1 | 2014 | 25 | 0.520 |
Why?
|
Coronary Artery Bypass | 9 | 2021 | 2400 | 0.510 |
Why?
|
Eicosapentaenoic Acid | 4 | 2022 | 553 | 0.500 |
Why?
|
Aortic Valve | 7 | 2021 | 1837 | 0.490 |
Why?
|
Practice Guidelines as Topic | 6 | 2020 | 7446 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2019 | 1996 | 0.480 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 568 | 0.460 |
Why?
|
Bronchoscopy | 2 | 2018 | 846 | 0.450 |
Why?
|
Humans | 146 | 2023 | 715818 | 0.450 |
Why?
|
Drug-Eluting Stents | 5 | 2014 | 719 | 0.440 |
Why?
|
Ticlopidine | 3 | 2015 | 884 | 0.430 |
Why?
|
Patient Selection | 9 | 2020 | 4294 | 0.410 |
Why?
|
Myocardial Ischemia | 4 | 2016 | 2137 | 0.410 |
Why?
|
Guideline Adherence | 5 | 2016 | 2322 | 0.410 |
Why?
|
Coated Materials, Biocompatible | 2 | 2018 | 319 | 0.410 |
Why?
|
Heart Valve Prosthesis | 4 | 2021 | 1497 | 0.400 |
Why?
|
Drug Costs | 2 | 2018 | 1170 | 0.400 |
Why?
|
Cerebral Revascularization | 1 | 2012 | 227 | 0.390 |
Why?
|
Transportation of Patients | 1 | 2011 | 183 | 0.390 |
Why?
|
Heart Septum | 2 | 2019 | 322 | 0.380 |
Why?
|
Femoral Artery | 4 | 2020 | 845 | 0.380 |
Why?
|
Lyme Disease | 2 | 2008 | 605 | 0.370 |
Why?
|
Coronary Stenosis | 5 | 2022 | 809 | 0.360 |
Why?
|
Angioplasty | 1 | 2012 | 374 | 0.350 |
Why?
|
Emergency Medical Services | 4 | 2011 | 1794 | 0.350 |
Why?
|
Ventricular Function, Left | 3 | 2019 | 3365 | 0.350 |
Why?
|
Cause of Death | 4 | 2020 | 3612 | 0.340 |
Why?
|
Aneurysm, False | 1 | 2011 | 283 | 0.340 |
Why?
|
Time Factors | 26 | 2020 | 40887 | 0.340 |
Why?
|
Saphenous Vein | 1 | 2011 | 512 | 0.340 |
Why?
|
Hemodynamics | 4 | 2021 | 4214 | 0.340 |
Why?
|
Heart Valve Prosthesis Implantation | 5 | 2021 | 1486 | 0.340 |
Why?
|
Mitral Valve Insufficiency | 4 | 2020 | 1345 | 0.330 |
Why?
|
Heart Arrest | 3 | 2019 | 1374 | 0.330 |
Why?
|
Stroke Volume | 4 | 2019 | 4487 | 0.330 |
Why?
|
Cardiac Surgical Procedures | 2 | 2020 | 3475 | 0.330 |
Why?
|
Endarterectomy, Carotid | 1 | 2012 | 527 | 0.320 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3163 | 0.320 |
Why?
|
Risk Factors | 34 | 2022 | 70879 | 0.320 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3280 | 0.320 |
Why?
|
Thrombosis | 5 | 2023 | 2843 | 0.320 |
Why?
|
Recombinant Proteins | 6 | 2017 | 6803 | 0.310 |
Why?
|
Aged | 57 | 2021 | 162468 | 0.310 |
Why?
|
Heart Aneurysm | 1 | 2007 | 123 | 0.310 |
Why?
|
Referral and Consultation | 1 | 2020 | 3452 | 0.310 |
Why?
|
Male | 81 | 2023 | 350352 | 0.310 |
Why?
|
Middle Aged | 59 | 2021 | 214666 | 0.300 |
Why?
|
Mandatory Reporting | 2 | 2018 | 123 | 0.300 |
Why?
|
Mitral Valve | 3 | 2020 | 1446 | 0.300 |
Why?
|
Echocardiography | 4 | 2020 | 5045 | 0.300 |
Why?
|
Heart Diseases | 1 | 2019 | 2754 | 0.300 |
Why?
|
Bioprosthesis | 2 | 2021 | 613 | 0.300 |
Why?
|
Aged, 80 and over | 25 | 2021 | 58326 | 0.290 |
Why?
|
Cardiovascular Surgical Procedures | 2 | 2020 | 207 | 0.290 |
Why?
|
Female | 76 | 2023 | 377229 | 0.290 |
Why?
|
Carotid Stenosis | 1 | 2012 | 812 | 0.280 |
Why?
|
Paclitaxel | 2 | 2018 | 1626 | 0.280 |
Why?
|
Popliteal Artery | 2 | 2018 | 308 | 0.260 |
Why?
|
Stroke | 6 | 2023 | 9507 | 0.250 |
Why?
|
Heart Failure | 7 | 2021 | 10041 | 0.250 |
Why?
|
Angina Pectoris, Variant | 1 | 2003 | 59 | 0.240 |
Why?
|
Acinonyx | 1 | 2023 | 4 | 0.240 |
Why?
|
Hemangiosarcoma | 1 | 2005 | 222 | 0.240 |
Why?
|
Retrospective Studies | 27 | 2021 | 72473 | 0.240 |
Why?
|
Heart Rupture, Post-Infarction | 1 | 2002 | 50 | 0.230 |
Why?
|
Erythrocyte Transfusion | 2 | 2020 | 537 | 0.230 |
Why?
|
United States | 30 | 2021 | 67910 | 0.230 |
Why?
|
Prosthesis Failure | 3 | 2021 | 1211 | 0.230 |
Why?
|
Hypoglycemia | 2 | 2007 | 813 | 0.220 |
Why?
|
Delivery of Health Care | 1 | 2020 | 4881 | 0.220 |
Why?
|
Endovascular Procedures | 4 | 2017 | 1933 | 0.220 |
Why?
|
Blood Coagulation Tests | 1 | 2003 | 267 | 0.220 |
Why?
|
Recovery of Function | 4 | 2019 | 2929 | 0.220 |
Why?
|
Troponin | 2 | 2019 | 506 | 0.220 |
Why?
|
Heart Neoplasms | 1 | 2005 | 382 | 0.210 |
Why?
|
Blood Glucose | 2 | 2007 | 6258 | 0.210 |
Why?
|
Predictive Value of Tests | 11 | 2022 | 15198 | 0.210 |
Why?
|
Tyrosine | 2 | 2003 | 1506 | 0.210 |
Why?
|
Postoperative Complications | 5 | 2019 | 15102 | 0.210 |
Why?
|
Myocarditis | 1 | 2008 | 697 | 0.210 |
Why?
|
Atrial Fibrillation | 8 | 2020 | 4562 | 0.210 |
Why?
|
Registries | 9 | 2020 | 8048 | 0.210 |
Why?
|
Heart Valve Diseases | 2 | 2019 | 1053 | 0.210 |
Why?
|
Mass Screening | 2 | 2019 | 5208 | 0.200 |
Why?
|
Blood Transfusion | 2 | 2019 | 1257 | 0.200 |
Why?
|
Bronchodilator Agents | 1 | 2004 | 511 | 0.200 |
Why?
|
Databases, Factual | 9 | 2019 | 7901 | 0.200 |
Why?
|
Tachycardia | 1 | 2003 | 603 | 0.200 |
Why?
|
Peptides | 4 | 2006 | 4384 | 0.200 |
Why?
|
Vascular Patency | 3 | 2018 | 841 | 0.200 |
Why?
|
Length of Stay | 6 | 2020 | 6270 | 0.190 |
Why?
|
Follow-Up Studies | 17 | 2021 | 39305 | 0.190 |
Why?
|
Hyperglycemia | 2 | 2007 | 1356 | 0.190 |
Why?
|
Risk Assessment | 10 | 2020 | 23476 | 0.190 |
Why?
|
Congresses as Topic | 2 | 2015 | 775 | 0.190 |
Why?
|
Coronary Occlusion | 1 | 2023 | 295 | 0.180 |
Why?
|
Angioplasty, Balloon | 2 | 2018 | 652 | 0.180 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2019 | 91 | 0.180 |
Why?
|
Hemostatic Techniques | 1 | 2020 | 118 | 0.180 |
Why?
|
Sirolimus | 4 | 2008 | 1560 | 0.180 |
Why?
|
Health Care Costs | 4 | 2019 | 3164 | 0.180 |
Why?
|
Matched-Pair Analysis | 1 | 2019 | 288 | 0.170 |
Why?
|
Patient Readmission | 4 | 2020 | 2980 | 0.170 |
Why?
|
Pericardial Effusion | 2 | 2014 | 236 | 0.170 |
Why?
|
Logistic Models | 6 | 2020 | 13623 | 0.170 |
Why?
|
Endpoint Determination | 1 | 2021 | 611 | 0.170 |
Why?
|
Punctures | 1 | 2019 | 366 | 0.170 |
Why?
|
Intracranial Hemorrhages | 3 | 2020 | 829 | 0.170 |
Why?
|
Cost-Benefit Analysis | 8 | 2018 | 5266 | 0.170 |
Why?
|
Cardiac Imaging Techniques | 1 | 2020 | 268 | 0.160 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2017 | 920 | 0.160 |
Why?
|
Clinical Trials as Topic | 5 | 2015 | 7960 | 0.160 |
Why?
|
Bronchial Fistula | 1 | 2018 | 77 | 0.160 |
Why?
|
Gastric Fistula | 1 | 2018 | 72 | 0.160 |
Why?
|
Nitroprusside | 1 | 2017 | 285 | 0.160 |
Why?
|
Septal Occluder Device | 1 | 2018 | 125 | 0.150 |
Why?
|
Survival Rate | 7 | 2021 | 13213 | 0.150 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2020 | 1552 | 0.150 |
Why?
|
Insurance Benefits | 1 | 2018 | 179 | 0.150 |
Why?
|
Coronary Circulation | 4 | 2012 | 1652 | 0.150 |
Why?
|
Hemoptysis | 1 | 2018 | 153 | 0.150 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2017 | 101 | 0.150 |
Why?
|
Drug Therapy, Combination | 7 | 2019 | 6552 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 9596 | 0.150 |
Why?
|
Gastroscopy | 1 | 2018 | 199 | 0.150 |
Why?
|
Angina Pectoris | 3 | 2012 | 1009 | 0.150 |
Why?
|
Prosthesis Design | 3 | 2021 | 2107 | 0.150 |
Why?
|
Radiography, Interventional | 2 | 2014 | 1087 | 0.150 |
Why?
|
Cardiovascular System | 1 | 2022 | 763 | 0.140 |
Why?
|
Ventricular Function | 1 | 2018 | 423 | 0.140 |
Why?
|
Ischemia | 2 | 2022 | 1906 | 0.140 |
Why?
|
Nitric Oxide | 1 | 2004 | 2123 | 0.140 |
Why?
|
Tricuspid Valve | 1 | 2018 | 394 | 0.140 |
Why?
|
Echocardiography, Stress | 1 | 2016 | 129 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2017 | 1113 | 0.140 |
Why?
|
Heart Ventricles | 3 | 2020 | 3801 | 0.140 |
Why?
|
Thrombocytopenia | 1 | 2003 | 1142 | 0.130 |
Why?
|
Financial Management | 1 | 2016 | 156 | 0.130 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1525 | 0.130 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 565 | 0.130 |
Why?
|
Cost Savings | 2 | 2018 | 916 | 0.130 |
Why?
|
Medicare | 4 | 2019 | 5791 | 0.130 |
Why?
|
Vasodilator Agents | 2 | 2017 | 1001 | 0.130 |
Why?
|
Societies, Medical | 4 | 2014 | 3754 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 1 | 2018 | 782 | 0.130 |
Why?
|
Vitamin K | 1 | 2016 | 286 | 0.130 |
Why?
|
Pericardiocentesis | 1 | 2014 | 73 | 0.130 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2014 | 47 | 0.130 |
Why?
|
Thallium | 2 | 2004 | 103 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 3 | 2004 | 764 | 0.130 |
Why?
|
Decision Support Techniques | 3 | 2020 | 2032 | 0.130 |
Why?
|
Health Policy | 2 | 2019 | 2650 | 0.130 |
Why?
|
Vascular Grafting | 2 | 2017 | 160 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2018 | 415 | 0.120 |
Why?
|
Pacemaker, Artificial | 1 | 2019 | 767 | 0.120 |
Why?
|
Purines | 1 | 2017 | 589 | 0.120 |
Why?
|
Research Report | 1 | 2017 | 358 | 0.120 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 157 | 0.120 |
Why?
|
Accreditation | 1 | 2016 | 446 | 0.120 |
Why?
|
Policy Making | 1 | 2017 | 542 | 0.120 |
Why?
|
Fatal Outcome | 3 | 2018 | 1879 | 0.120 |
Why?
|
Infection Control | 1 | 2020 | 954 | 0.120 |
Why?
|
Survival Analysis | 7 | 2012 | 10503 | 0.120 |
Why?
|
Workload | 1 | 2019 | 858 | 0.110 |
Why?
|
Suction | 2 | 2023 | 261 | 0.110 |
Why?
|
Patient Transfer | 2 | 2012 | 761 | 0.110 |
Why?
|
Heart | 2 | 2022 | 4315 | 0.110 |
Why?
|
Prospective Studies | 11 | 2023 | 51317 | 0.110 |
Why?
|
Disclosure | 1 | 2019 | 742 | 0.110 |
Why?
|
Echocardiography, Transesophageal | 2 | 2011 | 1113 | 0.110 |
Why?
|
Forecasting | 2 | 2019 | 2956 | 0.110 |
Why?
|
Pandemics | 3 | 2020 | 7313 | 0.110 |
Why?
|
Equipment Design | 2 | 2018 | 3587 | 0.110 |
Why?
|
Consensus | 6 | 2020 | 2744 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2020 | 1145 | 0.110 |
Why?
|
Heart Rate | 1 | 2003 | 4096 | 0.110 |
Why?
|
Propensity Score | 2 | 2016 | 1762 | 0.110 |
Why?
|
Atrial Flutter | 2 | 2004 | 252 | 0.100 |
Why?
|
Mentors | 1 | 2016 | 612 | 0.100 |
Why?
|
Neuropeptide Y | 1 | 2012 | 203 | 0.100 |
Why?
|
Body Surface Potential Mapping | 2 | 2010 | 236 | 0.100 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1474 | 0.100 |
Why?
|
Quality Improvement | 2 | 2019 | 3738 | 0.100 |
Why?
|
Health Systems Agencies | 1 | 2010 | 3 | 0.100 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1887 | 0.100 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2019 | 1193 | 0.100 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1216 | 0.100 |
Why?
|
Angina, Unstable | 3 | 2021 | 929 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 661 | 0.100 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2012 | 285 | 0.100 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2016 | 620 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2002 | 1834 | 0.100 |
Why?
|
Regional Health Planning | 1 | 2010 | 89 | 0.100 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3149 | 0.090 |
Why?
|
Calcinosis | 1 | 2018 | 1453 | 0.090 |
Why?
|
Quality-Adjusted Life Years | 2 | 2014 | 1627 | 0.090 |
Why?
|
Quality of Health Care | 2 | 2017 | 4282 | 0.090 |
Why?
|
Ventricular Fibrillation | 2 | 2013 | 534 | 0.090 |
Why?
|
Population Groups | 1 | 2010 | 200 | 0.090 |
Why?
|
Double-Blind Method | 6 | 2022 | 11945 | 0.090 |
Why?
|
Massachusetts | 3 | 2017 | 8743 | 0.090 |
Why?
|
Tachycardia, Ventricular | 2 | 2008 | 1214 | 0.090 |
Why?
|
Pulmonary Edema | 1 | 2011 | 422 | 0.090 |
Why?
|
Acute Disease | 4 | 2021 | 7142 | 0.090 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1673 | 0.090 |
Why?
|
Boston | 5 | 2017 | 9377 | 0.080 |
Why?
|
Natriuretic Agents | 1 | 2008 | 27 | 0.080 |
Why?
|
Angiography | 3 | 2018 | 1626 | 0.080 |
Why?
|
Lung | 5 | 2020 | 9739 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3494 | 0.080 |
Why?
|
Adult | 13 | 2020 | 212279 | 0.080 |
Why?
|
Vascular Surgical Procedures | 1 | 2017 | 1459 | 0.080 |
Why?
|
Atherectomy | 1 | 2007 | 44 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1187 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2016 | 11201 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 4 | 2020 | 20357 | 0.080 |
Why?
|
Angiogenic Proteins | 1 | 2007 | 106 | 0.080 |
Why?
|
Diabetes Mellitus | 2 | 2020 | 5463 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 2 | 2009 | 2144 | 0.080 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2009 | 481 | 0.080 |
Why?
|
Leadership | 1 | 2016 | 1344 | 0.080 |
Why?
|
Cardiovascular Diseases | 3 | 2020 | 14438 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2020 | 13219 | 0.080 |
Why?
|
Administration, Oral | 1 | 2015 | 3955 | 0.080 |
Why?
|
Regional Blood Flow | 2 | 2008 | 1558 | 0.080 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2008 | 326 | 0.080 |
Why?
|
Pyrazoles | 1 | 2017 | 1958 | 0.080 |
Why?
|
Dyspnea | 2 | 2005 | 1253 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1825 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2790 | 0.070 |
Why?
|
Radiography | 3 | 2015 | 6980 | 0.070 |
Why?
|
Health Status | 2 | 2017 | 4001 | 0.070 |
Why?
|
American Heart Association | 1 | 2010 | 977 | 0.070 |
Why?
|
Amiodarone | 2 | 2004 | 203 | 0.070 |
Why?
|
Injections, Intra-Arterial | 1 | 2005 | 198 | 0.070 |
Why?
|
Information Dissemination | 1 | 2014 | 1097 | 0.070 |
Why?
|
Hospitals | 1 | 2019 | 3375 | 0.070 |
Why?
|
Brachial Artery | 1 | 2007 | 368 | 0.070 |
Why?
|
Polysaccharides | 1 | 2012 | 995 | 0.070 |
Why?
|
Blood Urea Nitrogen | 1 | 2005 | 197 | 0.070 |
Why?
|
Hypercholesterolemia | 1 | 2012 | 1160 | 0.070 |
Why?
|
Ultrasonography | 2 | 2019 | 5922 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7499 | 0.070 |
Why?
|
Intermittent Claudication | 1 | 2007 | 304 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2010 | 986 | 0.070 |
Why?
|
Critical Care | 2 | 2014 | 2494 | 0.070 |
Why?
|
Recurrence | 4 | 2020 | 8240 | 0.070 |
Why?
|
New York | 2 | 2017 | 860 | 0.070 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2005 | 382 | 0.060 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2004 | 191 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3902 | 0.060 |
Why?
|
Tachycardia, Sinus | 1 | 2003 | 44 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2207 | 0.060 |
Why?
|
Death | 1 | 2008 | 581 | 0.060 |
Why?
|
Ascites | 1 | 2005 | 341 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3035 | 0.060 |
Why?
|
Coronary Disease | 2 | 2012 | 6150 | 0.060 |
Why?
|
Direct Service Costs | 1 | 2002 | 64 | 0.060 |
Why?
|
Vomiting | 1 | 2005 | 625 | 0.060 |
Why?
|
Incidence | 7 | 2021 | 20733 | 0.050 |
Why?
|
Medical Staff, Hospital | 1 | 2006 | 628 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 25 | 0.050 |
Why?
|
Skin Transplantation | 1 | 2007 | 1119 | 0.050 |
Why?
|
Metals | 1 | 2006 | 681 | 0.050 |
Why?
|
Renal Dialysis | 2 | 2018 | 1743 | 0.050 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1106 | 0.050 |
Why?
|
Creatinine | 2 | 2005 | 1898 | 0.050 |
Why?
|
Costs and Cost Analysis | 2 | 2019 | 1670 | 0.050 |
Why?
|
Edema | 1 | 2005 | 769 | 0.050 |
Why?
|
Axillary Artery | 1 | 2020 | 45 | 0.050 |
Why?
|
Disease Management | 1 | 2012 | 2523 | 0.050 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2003 | 503 | 0.050 |
Why?
|
Pericardium | 1 | 2005 | 661 | 0.050 |
Why?
|
Heart Conduction System | 2 | 2007 | 1029 | 0.050 |
Why?
|
Clinical Competence | 1 | 2016 | 4630 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1403 | 0.050 |
Why?
|
Thromboembolism | 1 | 2006 | 985 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2020 | 8890 | 0.050 |
Why?
|
Heart Atria | 1 | 2005 | 1254 | 0.050 |
Why?
|
Brachytherapy | 1 | 2007 | 1282 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2018 | 1581 | 0.040 |
Why?
|
Hypertriglyceridemia | 1 | 2021 | 293 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1785 | 0.040 |
Why?
|
Feasibility Studies | 3 | 2019 | 4905 | 0.040 |
Why?
|
Decision Making | 2 | 2009 | 3846 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 5902 | 0.040 |
Why?
|
Young Adult | 2 | 2015 | 56228 | 0.040 |
Why?
|
International Normalized Ratio | 1 | 2018 | 369 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2014 | 2768 | 0.040 |
Why?
|
Endarterectomy | 1 | 2017 | 202 | 0.040 |
Why?
|
Shock | 1 | 2018 | 317 | 0.040 |
Why?
|
Internship and Residency | 1 | 2016 | 5623 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2019 | 628 | 0.040 |
Why?
|
Hyperemia | 1 | 2017 | 219 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2018 | 271 | 0.040 |
Why?
|
Outpatients | 1 | 2003 | 1371 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2012 | 18197 | 0.030 |
Why?
|
Swine | 3 | 2012 | 5802 | 0.030 |
Why?
|
Troponin T | 1 | 2020 | 740 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2017 | 15911 | 0.030 |
Why?
|
Quality of Life | 2 | 2014 | 11722 | 0.030 |
Why?
|
Troponin I | 1 | 2019 | 627 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 742 | 0.030 |
Why?
|
Delphi Technique | 1 | 2017 | 727 | 0.030 |
Why?
|
Prevalence | 2 | 2018 | 14912 | 0.030 |
Why?
|
Skin | 1 | 2007 | 4297 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4193 | 0.030 |
Why?
|
Frail Elderly | 1 | 2018 | 607 | 0.030 |
Why?
|
Models, Economic | 1 | 2018 | 719 | 0.030 |
Why?
|
Triglycerides | 1 | 2022 | 2577 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2010 | 5038 | 0.030 |
Why?
|
Hospitalization | 2 | 2016 | 9745 | 0.030 |
Why?
|
Aspirin | 2 | 2019 | 3189 | 0.030 |
Why?
|
Hypoxia, Brain | 1 | 2013 | 134 | 0.030 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2012 | 48 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2054 | 0.030 |
Why?
|
Public-Private Sector Partnerships | 1 | 2013 | 127 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2018 | 939 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1073 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12483 | 0.030 |
Why?
|
Aortic Valve Insufficiency | 1 | 2016 | 574 | 0.030 |
Why?
|
Radial Artery | 1 | 2013 | 211 | 0.030 |
Why?
|
Sensitivity and Specificity | 4 | 2010 | 14902 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3683 | 0.030 |
Why?
|
Comorbidity | 2 | 2018 | 10435 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 351 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2017 | 19537 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 2013 | 377 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2014 | 1022 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1312 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2004 | 593 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2003 | 2547 | 0.020 |
Why?
|
Systole | 1 | 2013 | 986 | 0.020 |
Why?
|
Liver Diseases | 1 | 2018 | 1243 | 0.020 |
Why?
|
Warfarin | 1 | 2018 | 1476 | 0.020 |
Why?
|
Adolescent | 2 | 2012 | 85157 | 0.020 |
Why?
|
Inpatients | 1 | 2001 | 2255 | 0.020 |
Why?
|
Age Factors | 4 | 2014 | 18787 | 0.020 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2013 | 408 | 0.020 |
Why?
|
Radionuclide Imaging | 2 | 2004 | 2032 | 0.020 |
Why?
|
Animals | 5 | 2023 | 169404 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2473 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2013 | 722 | 0.020 |
Why?
|
Blood Pressure | 1 | 2004 | 8544 | 0.020 |
Why?
|
Kidney | 1 | 2003 | 6882 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9034 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9985 | 0.020 |
Why?
|
Algorithms | 2 | 2020 | 13758 | 0.020 |
Why?
|
Oxygen | 1 | 2019 | 4162 | 0.020 |
Why?
|
Prognosis | 2 | 2005 | 29007 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2017 | 1379 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1122 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2012 | 781 | 0.020 |
Why?
|
Statistics as Topic | 2 | 2004 | 2405 | 0.020 |
Why?
|
Ligation | 1 | 2007 | 480 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2008 | 6730 | 0.020 |
Why?
|
Cohort Studies | 2 | 2019 | 40032 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8075 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1438 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3030 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2013 | 2512 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1554 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2012 | 837 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2013 | 1612 | 0.020 |
Why?
|
Anemia | 1 | 2014 | 1419 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2003 | 9549 | 0.020 |
Why?
|
Israel | 1 | 2007 | 699 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2007 | 856 | 0.020 |
Why?
|
Myocardium | 2 | 2012 | 4909 | 0.020 |
Why?
|
Eligibility Determination | 1 | 2008 | 386 | 0.020 |
Why?
|
Arm | 1 | 2007 | 566 | 0.020 |
Why?
|
Regression Analysis | 1 | 2014 | 6495 | 0.020 |
Why?
|
Drug Delivery Systems | 2 | 2007 | 2210 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2008 | 1438 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2008 | 946 | 0.020 |
Why?
|
Vasodilation | 1 | 2007 | 957 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1294 | 0.010 |
Why?
|
Radiopharmaceuticals | 2 | 2004 | 2757 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2008 | 2292 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 23437 | 0.010 |
Why?
|
Hyperlipidemias | 1 | 2007 | 803 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1267 | 0.010 |
Why?
|
Bradycardia | 1 | 2003 | 285 | 0.010 |
Why?
|
Mice | 1 | 2008 | 80373 | 0.010 |
Why?
|
Health Resources | 1 | 2007 | 926 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2013 | 3579 | 0.010 |
Why?
|
Emotions | 1 | 2012 | 2449 | 0.010 |
Why?
|
Rest | 1 | 2004 | 875 | 0.010 |
Why?
|
Blotting, Western | 1 | 2007 | 5378 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3193 | 0.010 |
Why?
|
Mental Health | 1 | 2012 | 2682 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2007 | 1334 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2005 | 2104 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 6035 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2487 | 0.010 |
Why?
|
Exercise Test | 1 | 2004 | 2110 | 0.010 |
Why?
|
Physicians | 1 | 2014 | 4375 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2007 | 3493 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 2951 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6502 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 2774 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 3374 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 12460 | 0.010 |
Why?
|
Insulin | 1 | 2007 | 6648 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2007 | 10615 | 0.010 |
Why?
|
Smoking | 1 | 2007 | 8980 | 0.010 |
Why?
|
Sex Factors | 1 | 2004 | 10666 | 0.010 |
Why?
|
Hypertension | 1 | 2007 | 8270 | 0.010 |
Why?
|